Published in Br J Pharmacol on March 19, 2010
Headache and mechanical sensitization of human pericranial muscles after repeated intake of monosodium glutamate (MSG). J Headache Pain (2013) 0.82
Migraines Are Correlated with Higher Levels of Nitrate-, Nitrite-, and Nitric Oxide-Reducing Oral Microbes in the American Gut Project Cohort. mSystems (2016) 0.80
Transdermal glyceryl trinitrate as an effective adjunctive treatment with artemether for late-stage experimental cerebral malaria. Antimicrob Agents Chemother (2013) 0.79
Discovery and Clinical Evaluation of MK-8150, A Novel Nitric Oxide Donor With a Unique Mechanism of Nitric Oxide Release. J Am Heart Assoc (2016) 0.76
The International Classification of Headache Disorders: 2nd edition. Cephalalgia (2004) 49.94
Guide to Receptors and Channels (GRAC), 3rd edition. Br J Pharmacol (2008) 13.18
The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia (2007) 10.90
Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature (1994) 5.12
Migraine headache is not associated with cerebral or meningeal vasodilatation--a 3T magnetic resonance angiography study. Brain (2008) 3.38
Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet (2005) 3.27
Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol (1990) 3.25
Migraine. Lancet (2004) 3.20
Concepts of neural nitric oxide-mediated transmission. Eur J Neurosci (2008) 3.08
Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J (1998) 2.96
Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials. Lancet (1988) 2.84
Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet (2003) 2.83
Nitric oxide as modulator of neuronal function. Prog Neurobiol (2001) 2.41
Incidence and prognostic implications of stable angina pectoris among women and men. JAMA (2006) 2.16
Cardiovascular actions of sodium nitroprusside in animals and hypertensive patients. Circulation (1955) 2.15
Functional biology of the alpha(2)delta subunits of voltage-gated calcium channels. Trends Pharmacol Sci (2007) 2.13
A clinical trial of penta-erythritol tetranitrate, a khellin derivative (recordil), and iproniazid in angina of effort. Br Heart J (1959) 2.03
Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther (2006) 2.03
The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension (1988) 2.00
Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia (1995) 1.90
cGMP and S-nitrosylation: two routes for modulation of neuronal excitability by NO. Trends Neurosci (2002) 1.86
Reliability of the nitroglycerin provocative test in the diagnosis of neurovascular headaches. Cephalalgia (2004) 1.83
Molecular targets for antiepileptic drug development. Neurotherapeutics (2007) 1.78
Large-conductance, calcium-activated potassium channels: structural and functional implications. Pharmacol Ther (2005) 1.74
Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain (1994) 1.72
Nitric oxide blocks hKv1.5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism. Cardiovasc Res (2006) 1.71
Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ Res (2002) 1.69
Familial hemiplegic migraine mutations increase Ca(2+) influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. Proc Natl Acad Sci U S A (2002) 1.64
Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs. Cephalalgia (1996) 1.62
Presynaptic Ca2+ channels compete for channel type-preferring slots in altered neurotransmission arising from Ca2+ channelopathy. Neuron (2004) 1.56
Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med (2006) 1.53
Familial hemiplegic migraine. Neurotherapeutics (2007) 1.51
Functional consequences of mutations in the human alpha1A calcium channel subunit linked to familial hemiplegic migraine. J Neurosci (1999) 1.48
NO as a signalling molecule in the nervous system. Br J Pharmacol (2002) 1.46
EFNS guideline on the drug treatment of migraine - report of an EFNS task force. Eur J Neurol (2006) 1.43
Acute migraine in the Emergency Department: extending European principles of management. Intern Emerg Med (2008) 1.41
Migraine: a complex genetic disorder. Lancet Neurol (2007) 1.39
Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine. Headache (2004) 1.39
Serotonin and migraine: biology and clinical implications. Cephalalgia (2007) 1.39
Potassium channel function in vascular disease. Arterioscler Thromb Vasc Biol (2001) 1.38
Migraine: new molecular mechanisms. Neuroscientist (2005) 1.36
BK channel modulators: a comprehensive overview. Curr Med Chem (2008) 1.35
Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs. Curr Opin Pharmacol (2007) 1.35
Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia (2000) 1.32
Delayed inflammation in rat meninges: implications for migraine pathophysiology. Brain (2001) 1.29
The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther (2008) 1.27
Induction of persistent sodium current by exogenous and endogenous nitric oxide. J Biol Chem (2000) 1.26
Late sodium channel openings underlying epileptiform activity are preferentially diminished by the anticonvulsant phenytoin. J Neurophysiol (1997) 1.26
Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain (2003) 1.25
Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br J Pharmacol (2004) 1.25
NO hyperpolarizes pulmonary artery smooth muscle cells and decreases the intracellular Ca2+ concentration by activating voltage-gated K+ channels. Proc Natl Acad Sci U S A (1996) 1.23
Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. Neuroreport (1993) 1.22
The primary headaches: genetics, epigenetics and a behavioural genetic model. J Headache Pain (2008) 1.21
Nitric oxide modulates Ca(2+) channels in dorsal root ganglion neurons innervating rat urinary bladder. J Neurophysiol (2001) 1.20
Migraine: gene mutations and functional consequences. Curr Opin Neurol (2007) 1.20
The incidence and prevalence of cluster headache: a meta-analysis of population-based studies. Cephalalgia (2008) 1.20
Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack. Pain (1995) 1.19
CGRP antagonists: unravelling the role of CGRP in migraine. Trends Pharmacol Sci (2007) 1.18
Direct inhibition of expressed cardiac L-type Ca2+ channels by S-nitrosothiol nitric oxide donors. Circ Res (1997) 1.16
Animal models of migraine: looking at the component parts of a complex disorder. Eur J Neurosci (2006) 1.16
Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura. Cephalalgia (1999) 1.15
cGMP-mediated facilitation in nerve terminals by enhancement of the spike afterhyperpolarization. Neuron (2001) 1.15
The enigma of nitroglycerin bioactivation and nitrate tolerance: news, views and troubles. Br J Pharmacol (2008) 1.14
Nitric oxide as an autocrine regulator of sodium currents in baroreceptor neurons. Neuron (1998) 1.14
Organic nitrate esters: clinical use and mechanisms of actions. Pharmacol Rev (1991) 1.13
New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance. Clin Res Cardiol (2007) 1.12
Specific kinetic alterations of human CaV2.1 calcium channels produced by mutation S218L causing familial hemiplegic migraine and delayed cerebral edema and coma after minor head trauma. J Biol Chem (2005) 1.12
Medical advances in the treatment of congestive heart failure. Circulation (1993) 1.10
Nitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons. Eur J Neurosci (2006) 1.10
Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia (2008) 1.09
5-HT(1B) and 5-HT(1D) receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase. Brain Res (2001) 1.09
Cerebrospinal fluid glutamate levels in chronic migraine. Cephalalgia (2004) 1.09
Emerging therapies for migraine. Nat Clin Pract Neurol (2007) 1.08
Trait components provide tools to dissect the genetic susceptibility of migraine. Am J Hum Genet (2006) 1.07
Nitric oxide-dependent modulation of the delayed rectifier K+ current and the L-type Ca2+ current by ginsenoside Re, an ingredient of Panax ginseng, in guinea-pig cardiomyocytes. Br J Pharmacol (2004) 1.05
Direct actions of nitric oxide on rat neurohypophysial K+ channels. J Physiol (1999) 1.05
Release of glutamate and CGRP from trigeminal ganglion neurons: Role of calcium channels and 5-HT1 receptor signaling. Mol Pain (2008) 1.05
Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels. Br J Pharmacol (2002) 1.04
Nitric oxide increases cardiac IK1 by nitrosylation of cysteine 76 of Kir2.1 channels. Circ Res (2009) 1.03
Peroxynitrite: just an oxidative/nitrosative stressor or a physiological regulator as well? Br J Pharmacol (2006) 1.02
Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack. Cephalalgia (2005) 1.02
Antiepileptic drugs in migraine: from clinical aspects to cellular mechanisms. Trends Pharmacol Sci (2007) 1.02
The migraine cycle: patient burden of migraine during and between migraine attacks. Headache (2007) 1.01
Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients. Headache (2006) 1.01
Dopamine and migraine: biology and clinical implications. Cephalalgia (2007) 1.01
Nitric oxide modulates cardiac Na(+) channel via protein kinase A and protein kinase G. Circ Res (2001) 1.01
Modulation of ATP-sensitive potassium channels by cGMP-dependent protein kinase in rabbit ventricular myocytes. J Biol Chem (2001) 1.01
COOH-terminal association of human smooth muscle calcium channel Ca(v)1.2b with Src kinase protein binding domains: effect of nitrotyrosylation. Am J Physiol Cell Physiol (2007) 1.00
First data on effects and pharmacokinetics of isosorbide-5-mononitrate in normal man. Eur J Clin Pharmacol (1981) 0.98
Responsiveness of the trigeminovascular system to nitroglycerine in cluster headache patients. Brain (1997) 0.96
The therapeutic potential of neuronal K V 7 (KCNQ) channel modulators: an update. Expert Opin Ther Targets (2008) 0.95
Glyceryl trinitrate triggers premonitory symptoms in migraineurs. Pain (2004) 0.95
Hemicrania with oculosympathetic paresis from isosorbide dinitrate. N Engl J Med (1983) 0.94
The effect of anti-migraine compounds on nitric oxide-induced dilation of dural meningeal vessels. Eur J Pharmacol (2002) 0.94
Nitric oxide increases persistent sodium current in rat hippocampal neurons. J Physiol (1999) 0.93
Penta-erythritol tetranitrate in treatment of angina. Br Med J (1953) 0.93
Cardioprotective effects of glyceryl trinitrate: beyond vascular nitrate tolerance. Pharmacol Ther (2005) 0.93
Ten lessons on the epidemiology of migraine. Headache (2007) 0.93
Genetics in primary headaches. J Headache Pain (2007) 0.93
Microbial communities. Bioscience (1986) 2.36
Predatory prokaryotes: predation and primary consumption evolved in bacteria. Proc Natl Acad Sci U S A (1986) 2.17
Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase. Biochem Biophys Res Commun (1997) 2.14
The estimation of reduced ascorbic acid in blood serum and plasma. Biochem J (1936) 2.01
A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nat Genet (2000) 1.80
ADR1 activation domains contact the histone acetyltransferase GCN5 and the core transcriptional factor TFIIB. J Biol Chem (1996) 1.61
Comparative in vitro studies on native and recombinant human cationic trypsins. Cathepsin B is a possible pathological activator of trypsinogen in pancreatitis. J Biol Chem (2001) 1.34
The symbiotic microbial community of the Sonoran Desert termite: Pterotermes occidentis. Biosystems (1980) 1.23
Dissection of the ADR1 protein reveals multiple, functionally redundant activation domains interspersed with inhibitory regions: evidence for a repressor binding to the ADR1c region. Mol Cell Biol (1994) 1.21
Multiple RGS proteins alter neural G protein signaling to allow C. elegans to rapidly change behavior when fed. Genes Dev (2000) 1.19
ADR1c mutations enhance the ability of ADR1 to activate transcription by a mechanism that is independent of effects on cyclic AMP-dependent protein kinase phosphorylation of Ser-230. Mol Cell Biol (1992) 1.13
Insurance status and racial differences in uterine cancer survival: a study of patients in the National Cancer Database. Gynecol Oncol (2011) 1.10
A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context. Health Technol Assess (2006) 1.00
Association between a serotonin transporter promoter region polymorphism and mood response during tryptophan depletion. Mol Psychiatry (2002) 1.00
Patterns of mood changes throughout the reproductive cycle in healthy women without premenstrual dysphoric disorders. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.99
Relative therapeutic index between inhaled formoterol and salbutamol in asthma patients. Respir Med (2002) 0.95
Fluoxetine dilates isolated small cerebral arteries of rats and attenuates constrictions to serotonin, norepinephrine, and a voltage-dependent Ca(2+) channel opener. Stroke (1999) 0.94
Clinical effectiveness and cost-effectiveness of growth hormone in children: a systematic review and economic evaluation. Health Technol Assess (2002) 0.93
Treatment of patients with stage IV cancer: do the ends justify the means? Otolaryngol Head Neck Surg (1987) 0.93
rhDNase therapy for the treatment of cystic fibrosis patients with mild to moderate lung disease. J Clin Pharm Ther (1999) 0.91
Corticosterone peak is responsible for stress-induced elevation of glutamate in the hippocampus. Stress (1998) 0.89
Effect of stimulation of vagal and radial nerves on neuronal activity in the basal forebrain area of anaesthetized cats. Acta Physiol Hung (1983) 0.89
Slow wave sleep is accompanied by release of certain amino acids in the thalamus of cats. Neuroreport (1997) 0.89
Comparison of the membrane-filtration fluorescent antibody test, the enzyme-linked immunosorbent assay, and the polymerase chain reaction to detect Renibacterium salmoninarum in salmonid ovarian fluid. J Vet Diagn Invest (1998) 0.89
Alterations in prodynorphin gene expression and dynorphin levels in different brain regions after chronic administration of 14-methoxymetopon and oxycodone-6-oxime. Brain Res Bull (2006) 0.88
The electroretinogram and visual evoked potential of freely moving rats. Brain Res Bull (2001) 0.88
Electrophysiological effects of fluoxetine in mammalian cardiac tissues. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.88
Electrophysiological changes in rat ventricular and atrial myocardium at different stages of experimental diabetes. Acta Physiol Scand (1999) 0.87
Firing properties of cat basal forebrain neurones during sleep-wakefulness cycle. Electroencephalogr Clin Neurophysiol (1984) 0.86
A large, painless mass in the submandibular space. J Oral Maxillofac Surg (1992) 0.86
Microtubules in prokaryotes. Science (1978) 0.86
Facilitation of spike-wave discharge activity by lipopolysaccharides in Wistar Albino Glaxo/Rijswijk rats. Neuroscience (2006) 0.86
Possible evolutionary significance of spirochaetes. Proc R Soc Lond B Biol Sci (1979) 0.85
Molecular cloning of higher-plant 3-oxoacyl-(acyl carrier protein) reductase. Sequence identities with the nodG-gene product of the nitrogen-fixing soil bacterium Rhizobium meliloti. Biochem J (1992) 0.85
Potential partners: attitudes of family practice residents toward collaboration with social workers in their future practices. Soc Work Health Care (1976) 0.85
Are there extensions of thick filaments to the Z line in vertebrate and invertebrate striated muscle? J Ultrastruct Res (1977) 0.85
Effects of rosiglitazone on the configuration of action potentials and ion currents in canine ventricular cells. Br J Pharmacol (2011) 0.84
Sleep modifies retinal ganglion cell responses in the normal rat. Proc Natl Acad Sci U S A (2001) 0.84
Restorative effect of histamine on the transmembrane action potentials in potassium-depolarized guinea-pig auricle. Pol J Pharmacol Pharm (1978) 0.83
Receptors of peptides as therapeutic targets in epilepsy research. Curr Med Chem (2014) 0.83
[Giant epidermoid cyst in the floor of the mouth]. Fogorv Sz (1979) 0.83
Natural sleep modifies the rat electroretinogram. Proc Natl Acad Sci U S A (1994) 0.83
Two dopamine genes related to reports of childhood retrospective inattention and conduct disorder symptoms. Mol Psychiatry (2001) 0.83
A Gambian TNF haplotype matches the European HLA-A1,B8,DR3 and Chinese HLA-A33,B58,DR3 haplotypes. Tissue Antigens (2003) 0.83
Th1 and Th2 cell responses of type 1 diabetes patients and healthy controls to human heat-shock protein 60 peptides AA437-460 and AA394-408. Inflamm Res (2005) 0.82
A comparative study of apoptosis and cell proliferation in infantile and adult fibrosarcomas. Am J Clin Pathol (1996) 0.81
A novel effect of MPTP: the selective suppression of paradoxical sleep in cats. Brain Res (1990) 0.81
beta-Adrenergic catecholamine-dependent properties of rat myometrium primary cultures. Am J Physiol (1983) 0.81
Comparison of meloxicam and a glucosamine-chondroitin supplement in management of feline osteoarthritis. A double-blind randomised, placebo-controlled, prospective trial. Vet Comp Orthop Traumatol (2013) 0.80
Shared changes in gene expression in frontal cortex of four genetically modified mouse models of depression. Eur Neuropsychopharmacol (2010) 0.80
Effect of intrahippocampal dexamethasone on the levels of amino acid transmitters and neuronal excitability. Brain Res (1996) 0.80
Temporal distribution of the ganglion cell volleys in the normal rat optic nerve. Proc Natl Acad Sci U S A (2000) 0.80
Clinical effectiveness and cost-effectiveness of growth hormone in adults in relation to impact on quality of life: a systematic review and economic evaluation. Health Technol Assess (2002) 0.80
Methylglyoxal and cell viability. Int J Biochem (1994) 0.79
Comparative effects of prostaglandin F2alpha and A2 on the cardiac transmembrane potentials. Acta Biol Med Ger (1978) 0.79
Effects of hypnogenic vagal stimulation on thalamic neuronal activity in cats. Brain Res Bull (1985) 0.79
Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice. Brain Res Bull (2012) 0.79
Aggressive experience affects the sensitivity of neurons towards pharmacological treatment in the hypothalamic attack area. Behav Pharmacol (1998) 0.79
Role of slow delayed rectifier K+-current in QT prolongation in the alloxan-induced diabetic rabbit heart. Acta Physiol (Oxf) (2007) 0.79
A silicon-based microelectrode array with a microdrive for monitoring brainstem regions of freely moving rats. J Neural Eng (2016) 0.78
Using report cards to grade health plan quality. J Am Health Policy (1994) 0.78
Sustained depolarisation induces changes in the extracellular concentrations of purine and pyrimidine nucleosides in the rat thalamus. Neurochem Int (2000) 0.78
Cardiac electrophysiological effects of citalopram in guinea pig papillary muscle comparison with clomipramine. Gen Pharmacol (2000) 0.78
Inhibition of myocardial K+ channels by bromobenzoyl-methyladamantylamine, an adamantane derivative. Eur J Pharmacol (1982) 0.78
Serotonin reuptake inhibitors fluoxetine and citalopram relax intestinal smooth muscle. Can J Physiol Pharmacol (2001) 0.78
Effect of glutaurine on sleep-wakefulness cycle and aggressive behaviour in the cat. Acta Physiol Hung (1986) 0.78
Amino acid concentrations in cerebrospinal fluid of patients with multiple sclerosis. Acta Neurol Scand (1997) 0.78
Endocrinology trial design: adverse event reporting in randomised controlled trials of recombinant human GH in GH-deficient adults. J Endocrinol (2002) 0.78
Bimoclomol improves early electrophysiological signs of retinopathy in diabetic rats. Neuroreport (1998) 0.77
Mechanical properties of tenotomized and denervated-tenotomized muscles. Am J Physiol (1981) 0.77
Effects of vaccination with heat shock proteins on streptozotocin induced diabetes in histidine decarboxylase knockout mice. Inflamm Res (2008) 0.77
Improved dose homogeneity to the intact breast using three-dimensional treatment planning: technical considerations. Med Dosim (2000) 0.77
Uridine release during aminopyridine-induced epilepsy. Neurobiol Dis (2004) 0.77
The antiepileptic potential of nucleosides. Curr Med Chem (2014) 0.76
Physiological and pharmacological analysis of transmembrane action potentials of human atrial fibers. Adv Myocardiol (1985) 0.76
Glucocorticoids alter recovery processes in the rat retina. Neuroreport (1998) 0.76
Uneven regional distribution of nucleotide metabolism in human brain. Neurobiology (Bp) (1998) 0.76
Ventricular tachycardia in a neonate with mepivacaine toxicity. J Pediatr (1977) 0.76
Microtubules, undulipodia and Pillotina spirochetes. Ann N Y Acad Sci (1981) 0.76
Uridine is released by depolarization and inhibits unit activity in the rat hippocampus. Neuroreport (1999) 0.75
How patterns of bleached rods and cones become visual perceptual experiences: a proposal. Proc Natl Acad Sci U S A (2001) 0.75
Effects of H1- and H2-receptor antagonists on calcium-dependent action potentials produced by histamine in rabbit left auricles depolarized by potassium. Agents Actions (1981) 0.75
American Indians, African Americans: their common histories. JAMA (1992) 0.75
Safety of herbal remedies. J R Soc Med (1998) 0.75
Analysis of purine and pyrimidine bases, nucleosides and deoxynucleosides in brain microsamples (microdialysates and micropunches) and cerebrospinal fluid. Neurochem Int (1998) 0.75
Effect of CGP 36742 on the extracellular level of neurotransmitter amino acids in the thalamus. Neurochem Int (1999) 0.75
Uridine activates fast transmembrane Ca2+ ion fluxes in rat brain homogenates. Neuroreport (1999) 0.75
Local depletion of monoamines induced with in vivo voltammetry in the cat brain. Neuroscience (1991) 0.75
Antagonism between adenosine and bromobenzoyl-methyladamantylamine, a K+-channel blocker, in atrial myocardium of guinea pig. Eur J Pharmacol (1984) 0.75
Can the electrophysiological action of rosiglitazone explain its cardiac side effects? Curr Med Chem (2011) 0.75
[Epidural administration of a morphine-adrenaline-bupivacaine mixture in obstetric anesthesia]. Orv Hetil (1989) 0.75
[Results of the use of amine-fluoride preparations in orthodontic practice]. Fogorv Sz (1989) 0.75
Tonic and phasic modifications of viscerosensory evoked potentials during sleep in cats. Acta Physiol Hung (1983) 0.75
[Evaluation of the Schmuth index in orthodontic diagnosis]. Fogorv Sz (1989) 0.75
[Prognosis of dental arch insufficiency in the premolar and canine region by the Moyers index]. Fogorv Sz (1985) 0.75
Conditioned modification of viscerosensory evoked potentials during sleep and wakefulness in cats. Acta Physiol Hung (1983) 0.75
Transplantation of fetal fibroblasts and correction of enzymatic deficiencies in patients with Hunter's or Hurler's disorders. Transplantation (1986) 0.75
[Age and number of patients with dental crowding in case material from the Clinic of Pediatric Dentistry and Orthodontics in Budapest]. Stomatol DDR (1985) 0.75
[Tele-roentgen evaluation using the Ricketts method]. Fogorv Sz (1987) 0.75